dapsone has been researched along with Toxoplasmosis, Animal in 14 studies
Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A substantial reduction of brain cyst numbers could be obtained through a six week therapy with SDDS-pyrimethamine combination or a high titer anti-Toxoplasma serum." | 7.65 | The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice. ( Adusu, E; Masihi, KN; Tischer, I; Werner, H, 1977) |
| "A substantial reduction of brain cyst numbers could be obtained through a six week therapy with SDDS-pyrimethamine combination or a high titer anti-Toxoplasma serum." | 3.65 | The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice. ( Adusu, E; Masihi, KN; Tischer, I; Werner, H, 1977) |
| " Extending these experiments, we have now shown that roxithromycin at doses of 400 or 200 mg/kg/day combined with dapsone at doses of 5, 25 or 50 mg/kg/day completely prevented the development of T." | 1.30 | Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model. ( Brun-Pascaud, M; Chau, F; Derouin, F; Girard, PM, 1998) |
| "We examined the effect of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone, against Toxoplasma gondii." | 1.29 | Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. ( Arsenijevic, D; Chang, HR; Comte, R; Pechère, JC; Polak, A; Then, RL, 1994) |
| "Thus epiroprim is an active and potentially less toxic alternative pyrimethamine for the treatment of toxoplasmosis." | 1.29 | Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice. ( Allegra, CJ; Kovacs, JA; Martinez, A, 1996) |
| "Dapsone alone, which was administered at 100 mg/kg/day for 10 days from day 1 after infection, was unable to prevent parasite dissemination and only delayed the time to death of treated mice compared with the time of death of untreated controls." | 1.28 | Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine. ( Chastang, C; Chau, F; Derouin, F; Piketty, C; Pocidalo, JJ; Rouveix, B, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamberton, PH | 2 |
| Donnelly, CA | 2 |
| Webster, JP | 2 |
| Torrey, EF | 1 |
| Mehlhorn, H | 1 |
| Dankert, W | 1 |
| Hartman, PG | 1 |
| Then, RL | 2 |
| Chang, HR | 1 |
| Arsenijevic, D | 1 |
| Comte, R | 1 |
| Polak, A | 1 |
| Pechère, JC | 1 |
| Brun-Pascaud, M | 3 |
| Chau, F | 4 |
| Simonpoli, AM | 1 |
| Girard, PM | 3 |
| Derouin, F | 4 |
| Pocidalo, JJ | 2 |
| Richards, FO | 1 |
| Kovacs, JA | 2 |
| Luft, BJ | 1 |
| Martinez, A | 1 |
| Allegra, CJ | 1 |
| Garry, L | 1 |
| Jacobus, D | 1 |
| Werner, H | 1 |
| Masihi, KN | 1 |
| Tischer, I | 1 |
| Adusu, E | 1 |
| Kumar, PS | 1 |
| Kumar, R | 1 |
| Mohapatra, LN | 1 |
| Piketty, C | 1 |
| Chastang, C | 1 |
| Rouveix, B | 1 |
| Vischer, WA | 1 |
| Gill, HS | 1 |
| Prakash, O | 1 |
1 review available for dapsone and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Cats; Dapsone; Drug Therapy, | 1995 |
13 other studies available for dapsone and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Specificity of the Toxoplasma gondii-altered behaviour to definitive versus non-definitive host predation risk.
Topics: Animals; Behavior, Animal; Cats; Dapsone; Haloperidol; Pyrimethamine; Rats; Species Specificity; Tox | 2008 |
Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour.
Topics: Animals; Antimanic Agents; Antiprotozoal Agents; Antipsychotic Agents; Behavior, Animal; Cats; Dapso | 2006 |
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; F | 1995 |
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
Topics: Animals; Dapsone; Drug Synergism; Female; Folic Acid Antagonists; Mice; Toxoplasma; Toxoplasmosis, A | 1994 |
Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Brain; Dapsone; Drug Therapy, Combinat | 1994 |
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Dapsone; | 1996 |
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid | 1996 |
Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Disease Models, Animal; Dose-Respons | 1998 |
The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice.
Topics: Animals; Brain Diseases; Cysts; Dapsone; Female; Immunotherapy; Mice; Mice, Inbred Strains; Pyrimeth | 1977 |
Effect of SDDS (2-'sulfamonyl-4,4'-diamino diphenylsulphone) on experimental infection with Toxoplasma gondii in rabbits.
Topics: Animals; Antibody Formation; Dapsone; Female; Male; Rabbits; Sulfanilamides; Toxoplasma; Toxoplasmos | 1978 |
Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.
Topics: Animals; Cells, Cultured; Dapsone; Drug Combinations; Fibroblasts; Immunoenzyme Techniques; Mice; Mo | 1991 |
[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Topics: Aminobenzoates; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Syn | 1973 |
Chemotherapy of experimental Toxoplasma gondii (RH strain) infection.
Topics: Animals; Antiprotozoal Agents; Berberine Alkaloids; Dapsone; Demeclocycline; Hydrochloric Acid; Leuc | 1970 |